Questran and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Questran (cholestyramine), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Dipentum, and have Depression.

The phase IV clinical study analyzes which people have Dry skin when taking Questran. It is created by eHealthMe based on reports of 4,400 people who have side effects when taking Questran from the FDA, and is updated regularly.

What is Questran?

Questran has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 4,490 Questran users. Check the latest studies of Questran.

What is Dry skin?

Dry skin is found to be associated with 1,985 drugs and 2,354 conditions by eHealthMe. Check the latest studies of Dry skin.

On Jul, 18, 2026

4,400 people reported to have side effects when taking Questran.
Among them, 43 people (0.98%) have Dry skin.

Among these 43 people:

How long have people been on Questran when they have Dry skin? *

What is the gender of people who have Dry skin when taking Questran? *

female: 41.86 %
male: 58.14 %

What is the age of people who have Dry skin when taking Questran? *

What are other drugs people take besides Questran? *

What are other side effects people have besides Dry skin? *

Fatigue (feeling of tiredness): 22 people, 51.16%
Depression: 18 people, 41.86%
Duodenal Stenosis (block of the first part of the small intestine): 13 people, 30.23%
Acne (skin problems that cause pimples): 13 people, 30.23%
Inflammatory Bowel Disease: 13 people, 30.23%
Papilloma (small, noncancerous (benign) tumour): 13 people, 30.23%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 13 people, 30.23%
Syringomyelia (cavity forms within the spinal cord): 13 people, 30.23%
Cholangitis Sclerosing (infection and obstruction of bile duct): 13 people, 30.23%
Colitis (inflammation of colon): 13 people, 30.23%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 3 people, 6.98%
Colon Cancer: 3 people, 6.98%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.98%
Depression: 3 people, 6.98%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 4.65%
Gastrointestinal Stromal Tumor: 2 people, 4.65%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 4.65%
Prostate Cancer: 2 people, 4.65%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.65%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 2.33%

* Approximation only. Some reports may have incomplete information.

Do you take Questran and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Questran:

Questran (4,490 reports)

Dry skin treatments and more:

Dry skin (131,310 reports)

Browse all side effects of Questran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Dry skin (1,985 drugs)

Browse all the conditions that are associated with Dry skin:

Dry skin (2,354 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Questran) and Questran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.